Your browser doesn't support javascript.
loading
International Society of University Colon and Rectal Surgeons survey of surgeons' preference on rectal cancer treatment.
Dulskas, Audrius; Caushaj, Philip F; Grigoravicius, Domas; Zheng, Liu; Fortunato, Richard; Nunoo-Mensah, Joseph W; Samalavicius, Narimantas E.
Afiliación
  • Dulskas A; Department of Abdominal and General Surgery and Oncology, National Cancer Institute, Vilnius, Lithuania.
  • Caushaj PF; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Grigoravicius D; Department of Surgery, University of Connecticut School of Medicine and Hartford Hospital, Hartford, CT, USA.
  • Zheng L; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Fortunato R; Department of Colorectal Surgery, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Nunoo-Mensah JW; Department of Colorectal Surgery, Allegheny General Hospital, Pittsburgh, PA, USA.
  • Samalavicius NE; Department of Colorectal Surgery, King's College Hospital Foundation NHS Trust, London, UK.
Ann Coloproctol ; 39(4): 307-314, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36217808
PURPOSE: Rectal cancer treatment has a wide range of possible approaches from radical extirpative surgery to nonoperative watchful waiting following chemoradiotherapy, with or without, additional chemotherapy. Our goal was to assess the personal opinion of active practicing surgeons on rectal cancer treatment if he/she was the patient. METHODS: A panel of the International Society of University Colon and Rectal Surgeons (ISUCRS) selected 10 questions that were included in a questionnaire that included other items including demographics. The questionnaire was distributed electronically to ISUCRS fellows and other surgeons included in our database and remained open from April 16 to 28, 2020. RESULTS: One hundred sixty-three specialists completed the survey. The majority of surgeons (n=65, 39.9%) chose the minimally invasive (laparoscopic) surgery for their personal treatment of rectal cancer. For low-lying rectal cancer T1 and T2, the treatment choice was standard chemoradiation+local excision (n=60, 36.8%) followed by local excision±chemoradiotherapy if needed (n=55, 33.7%). In regards to locally advanced low rectal cancer T3 or greater, the preference of the responders was for laparoscopic surgery (n=65, 39.9%). We found a statistically significant relationship between surgeons' age and their preference for minimally invasive techniques demonstrating an age-based bias on senior surgeons' inclination toward open approach. CONCLUSION: Our survey reveals an age-based preference by surgeons for minimally invasive surgical techniques as well as organ-preserving techniques for personal treatment of treating rectal cancer. Only 1/4 of specialists do adhere to the international guidelines for treating early rectal cancer.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Qualitative_research Idioma: En Revista: Ann Coloproctol Año: 2023 Tipo del documento: Article País de afiliación: Lituania Pais de publicación: Corea del Sur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Qualitative_research Idioma: En Revista: Ann Coloproctol Año: 2023 Tipo del documento: Article País de afiliación: Lituania Pais de publicación: Corea del Sur